Targeting Hallmarks of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 283
Special Issue Editor
2. Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla 54090, Mexico
Interests: microRNAs; lncRNAs; cancer genomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains one of the most significant challenges in modern medicine, characterized by its complexity, heterogeneity, and ability to evolve rapidly. The pursuit of new, efficient drugs to combat cancer is a top priority in biomedical research. However, the development of such therapies is not a straightforward process. It requires a deep understanding of the fundamental mechanisms driving cancer progression, including the hallmark traits of cancer cells and the intricate signaling pathways involved in maintaining the tumor phenotype. In this context, the creation and utilization of biological models, such as organotypic cell cultures, and the study of epigenetic regulators, like long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), are crucial for advancing our ability to develop effective anti-cancer drugs.
The quest to develop new, efficient drugs to fight cancer is intrinsically linked to our understanding of the biological processes that underlie the disease. Biological models, from simple cell cultures to sophisticated animal models and organoids, are indispensable tools for studying the hallmarks of cancer and the signaling pathways that define the tumor phenotype. Additionally, the exploration of epigenetic regulators, such as lncRNAs and miRNAs, opens up new possibilities for targeted therapies that could complement existing treatments. As research in these areas continues to advance, it brings us closer to realizing the goal of developing more effective and personalized cancer therapies, ultimately improving outcomes for patients worldwide.
You may choose our Joint Special Issue in Cells.
Prof. Dr. Carlos Pérez Plasencia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epigenetic regulators
- organotypic culture models
- anticancer drugs
- hallmarks of cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
